Pilot-testing the Effect of Magnetic Mitohormesis Therapy for Treating Frailty in Older Adults - Trial NCT05930470
Access comprehensive clinical trial information for NCT05930470 through Pure Global AI's free database. This phase not specified trial is sponsored by Auburn University and is currently Recruiting. The study focuses on Frailty. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Auburn University
Timeline & Enrollment
N/A
Apr 26, 2023
Dec 30, 2024
Primary Outcome
Rate of adherence to intervention,Number of sites successfully recruited,Likert scale assessment of protocol implementation,Likert scale assessment of participant satisfaction
Summary
Thirty (30) adults with limited physical function will be recruited to participate in a
 double-blind pilot randomized controlled crossover trial in which all participants will
 receive 12-weeks of twice weekly MMT treatment in the first (Phase 1) or second half (Phase
 2) of the study period; during the control period, participants will receive sham treatment
 and will be blinded to the randomization.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05930470
Non-Device Trial